ThinkSono Secures £2.1M in Funding for Ultrasound AI
ThinkSono, a London, UK-based medical technology company, has recently secured £2.1M in funding. The funding round was led by id4 ventures, with participation from Brandenburg Kapital, Calm Storm Ventures, Dubai Angel Investors, CrowdCube, and Cur8 Capital, along with several angel investors and clinicians in vascular surgery. The company plans to utilize the funds to expand its operations and further enhance its research and development efforts.
Under the leadership of CEO Fouad Al Noor, ThinkSono specializes in ultrasound AI guidance solutions.
Their Guidance software empowers non-ultrasound trained healthcare professionals to accurately scan patients with suspected blood clots (DVT) and transmit the data for expert clinician evaluation, thereby streamlining the clinical process. DVT is a significant contributor to preventable hospital deaths worldwide, making the company's technology crucial in saving lives.
ThinkSono has solidified collaborations with hospitals throughout Europe, including establishments in the UK, Germany, and Greece. In addition to these partnerships, the company has announced strategic alliances with prominent healthcare organizations such as NYU Langone Health and Temple Health. Fouad Al Noor expressed excitement about this recent round of funding, affirming that it will drive the company towards achieving its goal of revolutionizing medical imaging technology and ultimately enhancing patient outcomes.
They've invested in ThinkSono
Get to know these Healthtech investors
Click here for a full list of 6,908+ startup investors in the UK